Persistent presumed allergic fungal rhinosinusitis during tezepelumab therapy with improvement after revision surgery: a case report.

Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen

http://www.ncbi.nlm.nih.gov/pubmed/42741183

Aasem Gharamah Alshehri; Bashayer Saad Hamoud Alsultan; Ghadah Saad H Alsultan; Leen Abdulmohsin Sarhan; Yahya Shabi

Sep 16, 2026